A recent report has shown that the oncogenic function of EZH2 in cells of CR prostate cancer is independent of its role as a transcriptional repressor and involves its the ability to act as a coactivator for critical transcription factors including the androgen receptor [16]. The gene discussed is EZH2; the disease is Familial prostate cancer.